Financials
Income statement
Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 56.0B | 53.7B | 48.2B | 52.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 5.5B | 4.9B | -599M | 4.9B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 27.5B | 26.7B | 27.4B | 25.1B |
Tax provision | 6.8B | 6.9B | 7.2B | 6.4B |
Net income | 21.5B | 20.3B | 20.2B | 18.7B |
Basic EPS | 56.9 | 53.8 | — | 49.7 |
Diluted EPS | 56.9 | 53.7 | — | 49.6 |
Basic average shares | 376.0M | 375.8M | — | 375.5M |
Diluted average shares | 376.5M | 376.5M | — | 376.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -128.7M | -78.4M | -124.8M | -73.5M |
Preferred stock dividends | — | — | — | — |